Skip to main content
. 2016 Sep 14;11(9):e0162594. doi: 10.1371/journal.pone.0162594

Table 3. ARQ 087 activity in FGFR dysregulated cell lines.

Cancer Cell Line FGFR Status [ref.] ARQ 087 GI50 μM
Colon NCI-H716 FGFR2 amp / FGFR2-COL14A1 fusion [44]/[45] 0.10
Gastric SNU-16 FGFR2 amp / PDHX-FGFR2 fusion [11]/[45] 0.10
Blood KG-1 FGFROP2-FGFR1 fusion [46] 0.13
Gastric KATO-III Amplified FGFR2 [11] 0.20
Ovarian SKOV3 Over expression FGFR4 [47] 0.28
Bladder J82 FGFR3 5652E [48] 0.30
Ovarian A2780 Over expression FGFR 4 [47] 0.33
Leukemia K-562 Over expression FGFR3 / 4 [49] 0.40
Breast MFM-223 Amplified FGFR2 [42] 0.50
Bladder RT112 FGFR3-TACC3 fusion [19] 0.65
Endometrial MFE-280 FGFR2 S252W [50] 0.9
Endometrial MFE-296 FGFR2 N549K [50] 1.0
Bladder RT4 FGFR3-TACC3 fusion [19] 1.2
Bladder SW-780 FGFR3-BAIAP2L1 fusion [19] 1.4
Endometrial AN3CA FGFR2 N549K [50] 1.7